StimCell Energetics Inc. Successfully Uplists to OTCQB Market
StimCell Energetics (OTCQB:STME) successfully uplisted to the OTCQB Venture Market, effective October 24, 2025. The company says the uplisting aims to enhance transparency, improve liquidity, and expand visibility with investors by adopting OTCQB reporting and governance standards.
Management highlighted the move as part of a growth strategy to attract new investors and support commercialization of the eBalance® wellness device, while continuing research and market expansion efforts.
StimCell Energetics (OTCQB:STME) si è ufficialmente quotata sul OTCQB Venture Market, con effetto a partire dal 24 ottobre 2025. L'azienda afferma che l'uplisting mira a aumentare la trasparenza, migliorare la liquidità e espandere la visibilità con gli investitori adottando gli standard di reporting e governance OTCQB. Il management ha evidenziato la mossa come parte di una strategia di crescita volta ad attrarre nuovi investitori e sostenere la commercializzazione del dispositivo benessere eBalance®, continuando al contempo le attività di ricerca ed espansione del mercato.
StimCell Energetics (OTCQB:STME) se ha listado con éxito en el OTCQB Venture Market, con efecto a partir del 24 de octubre de 2025. La compañía afirma que el uplisting tiene como objetivo aumentar la transparencia, mejorar la liquidez y incrementar la visibilidad entre los inversores al adoptar los estándares de reporte y gobernanza de OTCQB. La dirección destacó el movimiento como parte de una estrategia de crecimiento para atraer a nuevos inversores y apoyar la comercialización del dispositivo de bienestar eBalance®, mientras continúa con la investigación y la expansión del mercado.
StimCell Energetics (OTCQB:STME)가 성공적으로 OTCQB Venture Market으로 상장되었으며, 발효일은 2025년 10월 24일입니다. 회사는 상장이 투명성 제고, 유동성 개선, 그리고 투자자와의 가시성 확대를 목표로 OTCQB 보고 및 지배구조 표준을 채택함으로써 실현될 것이라고 밝혔습니다. 경영진은 이 조치를 새로운 투자자를 유치하고 eBalance® 웰니스 디바이스의 상용화를 지원하는 성장 전략의 일부로 강조했고, 동시에 연구 및 시장 확장 노력을 계속할 것이라고 덧붙였습니다.
StimCell Energetics (OTCQB:STME) a été admise avec succès sur le OTCQB Venture Market, effective à partir du 24 octobre 2025. La société indique que cet uplisting vise à renforcer la transparence, améliorer la liquidité et accroître la visibilité auprès des investisseurs en adoptant les normes de reporting et de gouvernance OTCQB. La direction a mis en avant ce mouvement comme faisant partie d'une stratégie de croissance pour attirer de nouveaux investisseurs et soutenir la commercialisation de l'appareil de bien-être eBalance®, tout en poursuivant les efforts de recherche et d'expansion du marché.
hat erfolgreich eine Auflistung am OTCQB Venture Market vorgenommen, wirksam ab dem 24. Oktober 2025. Das Unternehmen sagt, dass der Aufstieg darauf abzielt, Transparenz zu erhöhen, Liquidität zu verbessern und die Sichtbarkeit bei Investoren zu erweitern, indem OTCQB-Berichtspflichten und Governance-Standards übernommen werden. Das Management hob die Maßnahme als Teil einer Wachstumsstrategie hervor, um neue Investoren zu gewinnen und die Vermarktung des eBalance® Wellness-Geräts zu unterstützen, während gleichzeitig Forschung und Markterweiterung fortgesetzt werden.
StimCell Energetics (OTCQB:STME) تم إدراجها بنجاح في OTCQB Venture Market، واعتباراً من 24 أكتوبر 2025 سارية. تقول الشركة إن رفع مستوى التداول يهدف إلى تعزيز الشفافية، تحسين السيولة، وتوسيع الرؤية للمستثمرين من خلال اعتماد معايير التقارير والحوكمة في OTCQB. أكّدت الإدارة أن هذه الخطوة جزء من إستراتيجية نمو لجذب مستثمرين جدد ولدعم تسويق جهاز العافية eBalance®، مع مواصلة البحث وتوسيع الأسواق.
- Uplisting to OTCQB effective October 24, 2025
- Management cites improved transparency and reporting standards
- Company expects better liquidity and investor visibility
- None.
VANCOUVER, BC / ACCESS Newswire / October 24, 2025 / StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, and longevity, is pleased to announce its successful uplisting to the OTCQB Venture Market, effective October 24, 2025. This significant milestone reflects the company's commitment to enhancing transparency, improving liquidity, and expanding its visibility within the investment community.
The OTCQB, operated by OTC Markets Group, is a premier marketplace for early-stage and developing companies that meet high standards of financial reporting and corporate governance. By uplisting to the OTCQB, StimCell demonstrates its dedication to providing shareholders with greater access to financial information and a more robust trading platform.
"We are happy to achieve this uplisting to the OTCQB market, a key step in our growth strategy," said David Jeffs, Chief Executive Officer of StimCell Energetics Inc. "This move enhances our ability to attract new investors and supports our mission to bring our unique eBalance® wellness device, a cutting-edge solution designed to promote cellular energy maximization, to market. We look forward to leveraging this platform to further our business objectives and create long-term value for our shareholders."
The uplisting to OTCQB aligns with StimCell Energetics Inc.'s ongoing efforts to strengthen its market presence and advance its innovative projects through both research and market saturation while maintaining the highest standards of operational and financial transparency.
About StimCell Energetics Inc.
StimCell Energetics Inc. is a biotech company focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to: aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance® Technology and its eBalance® Home System.
On behalf of the Board of Directors of StimCell Energetics Inc.
David Jeffs
CEO, Director
For further information:
info@stimcell.com
www.StimCell.com
Forward Looking Statements
This press release contains forward-looking statements. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as "expects", "intends", "estimates", "projects", "anticipates", "believes", "could", and other similar words. All statements addressing product performance, events, or developments that the Company expects or anticipates will occur in the future are forward-looking statements. Because the statements are forward-looking, they should be evaluated in light of important risk factors and uncertainties, some of which are described in the Company's Quarterly, Annual and Current Reports filed with the United States Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should any of the Company's underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on Company's forward-looking statements. Except as required by law, StimCell Energetics Inc. disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. No stock exchange, securities commission or other regulatory body has reviewed nor accepts responsibility for the adequacy or accuracy of this release. Investors are advised to carefully review the reports and documents that StimCell Energetics Inc. files from time to time with the SEC, including its Annual, Quarterly and Current Reports.
SOURCE: StimCell Energetics Inc.
View the original press release on ACCESS Newswire
FAQ
What does StimCell Energetics uplisting to OTCQB (STME) mean for investors?
When did STME become listed on the OTCQB Venture Market?
How will the OTCQB uplisting affect liquidity for STME shares?
Will the OTCQB uplisting help StimCell commercialize the eBalance® device?
What standards did StimCell meet to join the OTCQB market (STME)?
